Fig. 2From: Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart reviewReason for development of most recent inhibitor by BPA therapy. BPA (Bypass Agent), BPA Px (Bypass Agent Prophylaxis), BPA OD (Bypass Agent On-Demand)Back to article page